Large-scale testing (Phase 3)Ended earlyNCT04642638
What this trial is testing
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVID-19 Disease
Inovio Pharmaceuticals 1,307